C Nézelof

3.3k total citations · 1 hit paper
132 papers, 2.4k citations indexed

About

C Nézelof is a scholar working on Immunology, Physiology and Molecular Biology. According to data from OpenAlex, C Nézelof has authored 132 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Immunology, 38 papers in Physiology and 33 papers in Molecular Biology. Recurrent topics in C Nézelof's work include Histiocytic Disorders and Treatments (32 papers), Mast cells and histamine (19 papers) and Eosinophilic Disorders and Syndromes (15 papers). C Nézelof is often cited by papers focused on Histiocytic Disorders and Treatments (32 papers), Mast cells and histamine (19 papers) and Eosinophilic Disorders and Syndromes (15 papers). C Nézelof collaborates with scholars based in France, United States and United Kingdom. C Nézelof's co-authors include F Basset, S Barbey, Françoise Basset, Francis Jaubert, Blaise E. Favara, Peter Bucsky, Stephan Ladisch, Alfred C. Feller, Gritta Janka‐Schaub and Jean Gogusev and has published in prestigious journals such as Journal of Clinical Investigation, The Journal of Clinical Endocrinology & Metabolism and PEDIATRICS.

In The Last Decade

C Nézelof

127 papers receiving 2.3k citations

Hit Papers

Contemporary classification of histiocytic disorders 1997 2026 2006 2016 1997 100 200 300 400 500

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
C Nézelof France 20 1.3k 736 627 533 397 132 2.4k
Valerie Broadbent United Kingdom 24 1.9k 1.4× 993 1.3× 1.1k 1.7× 278 0.5× 357 0.9× 48 2.2k
Michael Girschikofsky Austria 15 645 0.5× 900 1.2× 447 0.7× 638 1.2× 231 0.6× 33 2.1k
C. Larroche France 26 385 0.3× 399 0.5× 316 0.5× 758 1.4× 341 0.9× 68 2.3k
Kazuko Kudo Japan 30 439 0.3× 503 0.7× 357 0.6× 406 0.8× 148 0.4× 102 2.4k
Toshihiko Imamura Japan 25 422 0.3× 300 0.4× 302 0.5× 433 0.8× 138 0.3× 139 1.9k
Manfred Zierhut Germany 34 349 0.3× 171 0.2× 240 0.4× 337 0.6× 359 0.9× 227 4.9k
Marianne Kambouchner France 29 995 0.7× 178 0.2× 464 0.7× 307 0.6× 155 0.4× 80 2.5k
S. Herson France 33 187 0.1× 229 0.3× 423 0.7× 661 1.2× 401 1.0× 141 3.6k
B. Granel France 28 265 0.2× 123 0.2× 508 0.8× 559 1.0× 995 2.5× 200 2.9k
D. Bessis France 27 157 0.1× 217 0.3× 328 0.5× 335 0.6× 393 1.0× 182 2.2k

Countries citing papers authored by C Nézelof

Since Specialization
Citations

This map shows the geographic impact of C Nézelof's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C Nézelof with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C Nézelof more than expected).

Fields of papers citing papers by C Nézelof

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C Nézelof. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C Nézelof. The network helps show where C Nézelof may publish in the future.

Co-authorship network of co-authors of C Nézelof

This figure shows the co-authorship network connecting the top 25 collaborators of C Nézelof. A scholar is included among the top collaborators of C Nézelof based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C Nézelof. C Nézelof is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Murakami, Ichiro, Louise Telvi, Marc Jeanpierre, et al.. (2008). Molecular cytogenetic anomalies and phenotype alterations in a newly established cell line from Wilms tumor with diffuse anaplasia. Cancer Genetics and Cytogenetics. 184(1). 22–30. 7 indexed citations
2.
Nézelof, C & Jean‐Marc Guinebretière. (2006). [1879, Ernest Besnier inventor of the word "biopsy"].. PubMed. 56(18). 2081–5. 2 indexed citations
3.
Nézelof, C & Thomas A. Seemayer. (2004). [Robert Alan Good or the genius intuitions of an immunologist].. PubMed. 54(10). 1153–7. 1 indexed citations
4.
Gogusev, Jean, Louise Telvi, Ichiro Murakami, et al.. (2004). DOR-1, A novel CD10+ stromal cell line derived from progressive Langerhans cell histiocytosis of bone. Pediatric Blood & Cancer. 44(2). 128–137. 4 indexed citations
5.
Couturier, Daniel, F Dubois, M Huguier, et al.. (2004). La place des nouvelles méthodes basées sur l'apport de " preuves " dans la prise en charge des patients. Bulletin de l Académie Nationale de Médecine. 188(5). 803–811. 1 indexed citations
6.
Nézelof, C. (2002). Pierre Fid[egrave]le Bretonneau 1778-1862. A pioneer in understanding infectious diseases. Annals of Diagnostic Pathology. 6(1). 74–82. 1 indexed citations
7.
Nézelof, C, G Contesso, & Jean‐Marc Guinebretière. (2001). Ernest Besnier (1831-1909) : l'inventeur de la biopsie. Bulletin du Cancer. 88(8). 1 indexed citations
8.
Nézelof, C & G Contesso. (1999). Gustave Roussy (1874-1948) : un pionnier de la cancérologie. Bulletin du Cancer. 86(3). 1 indexed citations
9.
Nézelof, C & Françoise Basset. (1998). LANGERHANS CELL HISTIOCYTOSIS RESEARCH. Hematology/Oncology Clinics of North America. 12(2). 385–406. 55 indexed citations
10.
Nézelof, C, Maarten Egeler, Peter Bucsky, & Jean Gogusev. (1995). Malignant histiocytosis in childhood: A disease in quest of new nosological criteria. Medical and Pediatric Oncology. 25(2). 67–69. 4 indexed citations
11.
Armstrong, Elina, Kumar Kastury, Olga Aprelikova, et al.. (1993). FLT4 Receptor Tyrosine Kinase Gene Mapping to Chromosome Band 5q35 in Relation to the t(2;5), t(5;6), and t(3;5) Translocations. Genes Chromosomes and Cancer. 7(3). 144–151. 13 indexed citations
12.
Culine, Stéphane, Marie-Françoise Rousseau-Merck, Nicole Honoré, C Nézelof, & Birgitta Olofsson. (1992). Specific expression of theras-Relatedrab3A gene in human normal and malignant neuroendocrine cells. Cancer. 70(10). 2552–2556. 5 indexed citations
13.
Gaillard, Dominique, Raymonde Bouvier, E Sonsino, et al.. (1992). Nucleolar Organizer Regions in Congenital Mesoblastic Nephroma. Pediatric Pathology. 12(6). 811–821. 3 indexed citations
14.
Barbey, S, et al.. (1990). Del cell line: A “malignant histiocytosis” CD30 + T(5;6)(Q35;P21) cell line. International Journal of Cancer. 45(3). 546–553. 18 indexed citations
15.
Goldberg, J. & C Nézelof. (1989). Familial Lymphohistiocytosis: The Pathologist's View. Pediatric Hematology and Oncology. 6(3). 199–205. 5 indexed citations
16.
Nézelof, C, et al.. (1989). The Disappearance of Germinal Centers in Chronic Lymphadeno-Hepato-Splenomegaly Syndrome in Childhood: Report of Three Cases. Pediatric Pathology. 9(1). 57–71. 1 indexed citations
18.
Canioni, Danielle, C Fekete, & C Nézelof. (1989). Solitary Intestinal Fibromatosis: a Rare Cause of Neonatal Obstruction. Pediatric Pathology. 9(6). 719–724. 8 indexed citations
19.
Rousseau-Merck, Marie-Françoise, C Nézelof, Yves de Keyzer, et al.. (1988). PTH mRNA transcription analysis in infantile tumors associated with hypercalcemia. Cancer. 62(2). 303–308. 10 indexed citations
20.
Jouan, H, F Le Deist, & C Nézelof. (1987). Omenn's syndrome—Pathologic arguments in favor of a graft versus host pathogenesis: A report of nine cases. Human Pathology. 18(11). 1101–1108. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026